相关实验视频
Updated: Jul 15, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.9K
心脏外科手术中的外科手术期间血糖管理:叙述性综述
Yada Thongsuk1, Nian Chih Hwang2
1Department of Anesthesiology, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Department of Cardiothoracic Anaesthesia, National Heart Centre, Singapore.
Journal of cardiothoracic and vascular anesthesia
|September 24, 2023
概括
在心脏手术患者中保持最佳血糖水平至关重要. 严格的血糖控制可以导致低血糖症,这是一个影响术后结果的重大不良事件.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 手术医学 手术医学
背景情况:
- 外科手术期间的高血糖和失血糖与心脏手术患者的发病率和死亡率增加有关.
- 异常的血糖波动 (失糖症) 源于手术压力,技术,药物和患者特定因素.
- 血糖水平高低都会对心脏手术后的结果产生负面影响.
研究的目的:
- 在心脏外科手术中审查外科手术期间的葡萄糖平衡.
- 讨论这种患者群体中失糖症的病理生理学.
- 检查影响血糖控制和当前管理策略的因素.
主要方法:
- 在心脏外科手术中对术后血糖控制的文献综述.
- 分析导致失糖症的因素.
- 对管理血糖的当前临床实践的概述.
主要成果:
- 低血糖是心脏手术中的一个重要问题,影响患者的治疗结果.
- 低血糖是密集血糖控制工作期间的主要不良事件.
- 关于理想的外科手术期间葡萄糖目标,没有确立的共识.
结论:
- 在心脏外科手术中,有效的术后血糖管理是必不可少的,但具有挑战性.
- 平衡高血糖和低血糖风险对于改善患者的治疗结果至关重要.
- 需要进一步的研究来确定最佳的血糖控制策略.
相关概念视频
Cardiomyopathy VII: Pre and Post Operative Nursing Management
15
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
15
Peripheral Artery Disease V: Postoperative Nursing Management
12
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
12
Hypoglycemia and Glucagon
287
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
287
Aneurysm IV: Nursing Management
8
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
8
Diabetes: Management and Pharmacotherapy
302
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
302
Oral Hypoglycemic Agents: Glinides
176
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
176

